{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T10:30:29Z","timestamp":1783593029402,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Despite the availability of patented non-invasive methods, evaluation of the degrees of liver fibrosis remains difficult when conducting a retrospective study. Such inadequacy is largely caused by requirement of biochemical parameters rarely performed in routine clinical tests. We developed a novel fibrosis HB-F score using commonly performed tests for HBV infected patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>424 patients with chronic HBV infection were included. Using clinical and virological data, HB-F score was developed from a training cohort (n\u2009=\u2009213) and validated in a separate cohort (n\u2009=\u2009211). The performance was compared with five other unpatented scores using ROC curves.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Univariate and multivariate analysis revealed that age, AST\/ALT ratio, platelet count and prothrombin time prolongation were significantly associated with the ISHAK fibrosis score, and were used to calculate the HB-F score. When HB-F was used to assess prominent fibrosis and cirrhosis, the AUC was 0.81 and 0.80 respectively in the training cohort, and 0.80 and 0.76 respectively in the validation cohort. HB-F had the highest AUC compared with other scores. Furthermore, in assessing paired liver biopsies with increase or decrease of ISHAK scores, HB-F showed significant change in the same direction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>A new non-invasive score was developed, which could be used to assess severity of liver fibrosis in retrospective longitudinal studies in HBV patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1756-0500-6-212","type":"journal-article","created":{"date-parts":[[2013,5,27]],"date-time":"2013-05-27T06:14:20Z","timestamp":1369635260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Development of a non-invasive fibrosis test for chronic hepatitis B patients and comparison with other unpatented scores"],"prefix":"10.1186","volume":"6","author":[{"given":"Chao-Wei","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kung-Hao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiu-Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chien","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chau-Ting","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,27]]},"reference":[{"key":"2228_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","volume":"11","author":"D Lavanchy","year":"2004","unstructured":"Lavanchy D: Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004, 11: 97-107. 10.1046\/j.1365-2893.2003.00487.x.","journal-title":"J Viral Hepat"},{"key":"2228_CR2","first-page":"1046","volume":"41","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA: Liver fibrosis. J Clin Invest. 2005, 41: 1046-1055.","journal-title":"J Clin Invest"},{"key":"2228_CR3","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L: Histologic grading and staging of chronic hepatitis. J Hepatol. 1995, 22: 696-699. 10.1016\/0168-8278(95)80226-6.","journal-title":"J Hepatol"},{"key":"2228_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/hep.1840010511","volume":"1","author":"RG Knodell","year":"1981","unstructured":"Knodell RG, Ishak KG, Black WC: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981, 1: 431-435. 10.1002\/hep.1840010511.","journal-title":"Hepatology"},{"key":"2228_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa P, Poynard T: An algorithm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group. Hepatology. 1996, 24: 289-293. 10.1002\/hep.510240201.","journal-title":"Hepatology"},{"key":"2228_CR6","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1056\/NEJMoa033364","volume":"351","author":"YF Liaw","year":"2004","unstructured":"Liaw YF, Sung JJ, Chow WC: Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004, 351: 1521-1531. 10.1056\/NEJMoa033364.","journal-title":"N Engl J Med"},{"key":"2228_CR7","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","volume":"47","author":"ZD Goodman","year":"2007","unstructured":"Goodman ZD: Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol. 2007, 47: 598-607. 10.1016\/j.jhep.2007.07.006.","journal-title":"J Hepatol"},{"key":"2228_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2214\/AJR.11.7517","volume":"199","author":"G Ferrailoi","year":"2012","unstructured":"Ferrailoi G, Tinelli C, Malfitano A: Performance of real-time strain elastography, transient elastography, and aspartate-to-platelet ratio index in the assessment of fibrosisi in chronic hepatitis C. Am J Roentgenol. 2012, 199: 19-25. 10.2214\/AJR.11.7517.","journal-title":"Am J Roentgenol"},{"key":"2228_CR9","doi-asserted-by":"publisher","first-page":"e36676","DOI":"10.1371\/journal.pone.0036676","volume":"7","author":"SU Kim","year":"2012","unstructured":"Kim SU, Lee JH, Kim Do Y: Prediction of liver\u2013related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis. PLoS One. 2012, 7: e36676-10.1371\/journal.pone.0036676.","journal-title":"PLoS One"},{"key":"2228_CR10","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1007\/s10620-012-2044-4","volume":"57","author":"KT Yoon","year":"2012","unstructured":"Yoon KT, Lim SM, Park JY: Liver stiffiness measurement using acoustic radiation force impulse (ARFI) elastography and effect of necroinflammation. Dig Dis Sci. 2012, 57: 1682-1691. 10.1007\/s10620-012-2044-4.","journal-title":"Dig Dis Sci"},{"key":"2228_CR11","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/j.1478-3231.2011.02660.x","volume":"32","author":"AC Cardoso","year":"2012","unstructured":"Cardoso AC, Carvalho-Filho RJ, Stern C: Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver Int. 2012, 32: 612-621. 10.1111\/j.1478-3231.2011.02660.x.","journal-title":"Liver Int"},{"key":"2228_CR12","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0016-5085(88)80022-2","volume":"95","author":"AL Williams","year":"1988","unstructured":"Williams AL, Hoofnagle JH: Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis: relationship to cirrhosis. Gastroenterology. 1988, 95: 734-739.","journal-title":"Gastroenterology"},{"key":"2228_CR13","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ: A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003, 38: 518-526.","journal-title":"Hepatology"},{"key":"2228_CR14","first-page":"77","volume":"60","author":"T Ohta","year":"2006","unstructured":"Ohta T, Sakaguchi K, Fujiwara A: Simple surrogate index of the fibrosis stage in chronic hepatitis C patients using platelet count and serum albumin level. Acta Med Okayama. 2006, 60: 77-84.","journal-title":"Acta Med Okayama"},{"key":"2228_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/hep.21520","volume":"45","author":"M Koda","year":"2007","unstructured":"Koda M, Matunaga Y, Kawakami M: FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology. 2007, 45: 297-306. 10.1002\/hep.21520.","journal-title":"Hepatology"},{"key":"2228_CR16","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N: Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006, 43: 1317-1325. 10.1002\/hep.21178.","journal-title":"Hepatology"},{"key":"2228_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B: FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and FibroTest. Hepatology. 2007, 46: 32-36. 10.1002\/hep.21669.","journal-title":"Hepatology"},{"key":"2228_CR18","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3851\/IMP1570","volume":"15","author":"T Poynard","year":"2010","unstructured":"Poynard T, Ngo Y, Munteanu M: Biomarkers of liver injury for hepatitis clinical trial: a meta-analysis of longitudinal studies. Antivir Ther. 2010, 15: 617-631. 10.3851\/IMP1570.","journal-title":"Antivir Ther"},{"key":"2228_CR19","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3109\/00365521.2011.574725","volume":"46","author":"KJ Stibbe","year":"2011","unstructured":"Stibbe KJ, Verveer C, Francke J: Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients. Scand J Gastroentero. 2011, 46: 962-972. 10.3109\/00365521.2011.574725.","journal-title":"Scand J Gastroentero"},{"key":"2228_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11901-011-0096-0","volume":"10","author":"T Poynard","year":"2011","unstructured":"Poynard T, Ngo Y, Munteanu M: Noninvasive markers of hepatitis fibrosis in chronic hepatitis B. Curr Hepat Rep. 2011, 10: 87-97. 10.1007\/s11901-011-0096-0.","journal-title":"Curr Hepat Rep"},{"key":"2228_CR21","doi-asserted-by":"publisher","first-page":"e35825","DOI":"10.1371\/journal.pone.0035825","volume":"7","author":"BK Kim","year":"2012","unstructured":"Kim BK, Kim SU, Kim HS: Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B. PLoS One. 2012, 7: e35825-10.1371\/journal.pone.0035825.","journal-title":"PLoS One"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-6-212.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:15:33Z","timestamp":1630541733000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-6-212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,27]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2228"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-6-212","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,27]]},"assertion":[{"value":"27 December 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"212"}}